Skip to main content

S32 — Portfolio, Page 3

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

109
Companies
$11.2B
Total invested
$103.2M
Avg. check
41
Industries
Biotechnology 13Artificial Intelligence (AI) 8Health Care 7Information Technology 6Medical 5Cyber Security 4+35 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 49–72 of 109
Stairwell
October 2022

Stairwell is a cybersecurity company that offers an Automated Threat Detection and Response platform that attackers can’t detect or evade.

Cyber Security · Mountain View$45.0M Series B
Nested Therapeutics
October 2022

Nested Therapeutics aims to advance precision oncology medicine by finding new driver mutations.

Biotechnology · Cambridge$90.0M Series A
Spectral
August 2022

Spectral is a protocol for programmable creditworthiness.

Blockchain · New Rochelle$23.0M Venture - Series Unknown
MOMA Therapeutics
May 2022

MOMA Therapeutics operates as a biotechnology company.

Biotechnology · Cambridge$150.0M Series B
Celsius Therapeutics
March 2022

Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.

Biotechnology · Cambridge$83.0M Series B
Satellite Bio
March 2022

Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering.

Biopharma · Newton$82.5M Series A
Nodexus
December 2021

Nodexus is democratizing access to live single cells for applications including gene editing, drug development, and more.

Biopharma · San Jose$30.0M Series A
Exai Bio
December 2021

Exai Bio is an orphan non-coding RNAs and AI-based liquid biopsy company.

Biotechnology · Palo Alto$67.5M Series A
Teckro
November 2021

Teckro is a life science technology company that is rethinking every element of clinical research.

Computer · New York$25.0M Venture - Series Unknown
Mekonos
November 2021

Mekonos creates a proprietary cell-engineering platform designed for cell therapies on a chip.

Biotechnology · Alameda$25.0M Series A
Parthenon Therapeutics
November 2021

Parthenon Therapeutics is a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment.

Biotechnology · Cambridge$65.0M Series A
Gretel
October 2021

Gretel is a multimodal synthetic data platform that leverages advanced generative AI and privacy-enhancing technologies.

Artificial Intelligence (AI) · San Diego$52.2M Series B
Outtake
January 2026

Outtake is a digital trust platform automating threat classification, detection, and response to enhance enterprise cybersecurity measures.

Artificial Intelligence (AI) · Brooklyn$40.0M Series B
Dave
January 2026

Dave is a banking app that offers customers banking, financial insights, overdraft protection, and building credit products.

Banking · Los AngelesUndisclosed
Celularity
December 2025

Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies.

Biotechnology · Florham Park$10.0M Post Ipo Debt
SandboxAQ
December 2025

SandboxAQ develops AI and quantum technology solutions that enhance biopharma, cybersecurity, and materials science.

Artificial Intelligence (AI) · Palo AltoPrivate Equity
Aspen Neuroscience
November 2025

Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.

Biotechnology · San Diego$115.0M Series C
Beacon Biosignals
November 2025

Beacon Biosignals is a neurotechnology company that brings precision neuroscience into clinical trials and treatments.

Artificial Intelligence (AI) · Boston$86.0M Series B
Octave
October 2025

Octave is a precision care company that provides diagnostic tools and care solutions for neurodegenerative diseases.

Biotechnology · Menlo ParkGrant
Phaidra
October 2025

Phaidra provides AI and ML solutions to accelerate performance in large-scale industries.

Artificial Intelligence (AI) · Seattle$50.0M Series B
Sola Security
September 2025

Sola Security provides a self-serve cybersecurity platform that enables organizations to build, customize, and manage security tools.

Artificial Intelligence (AI) · Tel Aviv-jaffa$35.0M Series A
Owl AI
June 2025

Owl AI is a sports technology company that uses artificial intelligence to improve performance analytics and decision-making in sports.

Analytics · San Francisco$11.0M Seed
Inductive Bio
May 2025

Inductive Bio provides the information, machine learning, tools, and know-how required to resolve ADMET issues.

Biotechnology · San Francisco$25.0M Series A
Arbor Biotechnologies
March 2025

Arbor Biotechnologies is a biotechnology company specializing in next-generation gene editing therapeutics to treat genetic diseases.

Artificial Intelligence (AI) · Cambridge$73.9M Series C

Where S32 invests

Biotechnology13
Artificial Intelligence (AI)8
Health Care7
Information Technology6
Medical5
Cyber Security4

About S32's portfolio

How many companies has S32 invested in?▸

S32 has invested in 109 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does S32 invest in?▸

S32's top investment sectors include Biotechnology, Artificial Intelligence (AI), Health Care, Information Technology, Medical. The firm invests across 41 different industry categories.

What is S32's largest investment?▸

Among tracked funding rounds, MOMA Therapeutics received $150.0M in a Series B round. S32's total known invested capital is $11.2B.

What is the average investment size for S32?▸

S32's average investment size is $103.2M across its portfolio of 109 companies.

What are S32's most recent investments?▸

Recent S32 portfolio additions include Stairwell, Nested Therapeutics, Spectral, MOMA Therapeutics, Celsius Therapeutics. These companies were founded in 2020 or later.

Reach the founders behind these 109 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →